|
|
|
| 
|
|
|
My Recent Searches
|
|
|
|
|
|
|
|
|
Guardant Health, Inc. (GH) |
|
|
$0.00 0.00 (0.00%) as of 4:30 Fri 2/14
|
|
Download |
|
|
| |
| |
| Exchange: |
N/A |
| Security
Type: |
Common |
| Shares
Out: |
121,380,000 |
| Market
Cap: |
N/A |
| Last
Volume: |
0 |
Avg
Vol: |
0 |
| 52
Week Range: |
$0 - $0 |
|
| Level
I Sector: |
N/A |
| Level
II Sector: |
N/A |
| Level
III Sector: |
N/A |
|
Member Indexes:
|
Rankings:
|
|
| Insider 3 Months : - |
| Insider 6 Months : - |
| Insider 3/6 Months : - |
|
| Guru Rank Number : - |
| Guru Rank Value : - |
| Guru Occurances : - |
|
|
|
|
|
| |
|
Company Profile Guardant Health is a precision oncology company focused on helping conquer cancer globally through use of its proprietary blood-based tests, data sets and analytics. Co. is engaged in the clinical liquid biopsy market with its Guardant360 and GuardantOMNI tests. Co.'s Guardant360 test is a molecular diagnostic test measuring a number of cancer-related genes and its GuardantOMNI test has a 500-gene panel, both of which analyze circulating tumor DNA in blood. In addition, Co. is developing tests from its LUNAR-1 program for minimal residual disease and recurrence detection in cancer survivors, and its LUNAR-2 program for early detection of cancer.
|
|
|
D/I:
|
|
|
D
is for direct shares.
I is
for indirect shares.
D/I
refers to the Direct or Indirect
shares traded vs. held. |
|
|
|
Forms:
|
|
|
A
Form 4 is a form filed
by an insider to indicate a change
in ownership.
A Form
3 is a form filed by
an insider to indicate an
initial ownership of a security. |
|
|
|
3m +/-:
|
|
|
|
This
represents the company's 3 month
price change. The initial price
is based on the closing price
of the stock on the day the transaction
took place. Purchases & sales
are viewed as long & short
positions respectively.
|
|
|
|
Actions:
|
|
|
| B |
Buy |
| S |
Sell |
| OE |
Option
Exercised |
| A |
Acquired |
| D |
Disposed |
| AB |
Automatic
Buy |
| AS |
Automatic
Sell |
| IO |
Initial
Ownership |
|
|
|
|
Download:
|
|
|
Download only Transactions
Forms. (Default)
Download
only Summary Infomation.
Download
both Transactions and Summary Data
|
|
|
|
|
| |
| |
Summary (Direct Transactions Only)  |
3 Months |
6 Months |
12 Months |
24 Months |
| Total Shares Bought |
2,187 |
2,187 |
2,187 |
98,220 |
| Total Buy Value |
$38,963 |
$38,963 |
$38,963 |
$2,585,297 |
| Total People Bought |
1 |
1 |
1 |
2 |
| Total Buy Transactions |
1 |
1 |
1 |
4 |
| Total Shares Sold |
100 |
200 |
8,325 |
31,716 |
| Total Sell Value |
$2,787 |
$4,692 |
$233,035 |
$1,293,892 |
| Total People Sold |
1 |
1 |
2 |
3 |
| Total Sell Transactions |
1 |
2 |
6 |
12 |
| End Date |
2024-03-17 |
2023-12-15 |
2023-06-16 |
2022-06-16 |
|
| Filer's Name |
Relation Title |
Off-Dir-10% |
Tran. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
  Joyce Meghan V. |
Director |
– • – |
2023-06-04 |
4 |
OE |
$0.00 |
$0 |
D/D |
66 |
1,459 |
|
- |
|
| Chudova Darya |
Chief Technology Officer |
• – – |
2023-06-01 |
4 |
D |
$31.39 |
$3,453 |
D/D |
(110) |
12,630 |
|
- |
|
| Chudova Darya |
Chief Technology Officer |
• – – |
2023-06-01 |
4 |
OE |
$0.00 |
$0 |
D/D |
316 |
12,740 |
|
- |
|
| Saia John G. |
Chief Legal Officer |
• – – |
2023-06-01 |
4 |
D |
$31.39 |
$2,856 |
D/D |
(91) |
18,052 |
|
- |
|
| Saia John G. |
Chief Legal Officer |
• – – |
2023-06-01 |
4 |
OE |
$0.00 |
$0 |
D/D |
263 |
18,143 |
|
- |
|
| Merrill Amelia |
SVP, People |
• – – |
2023-06-01 |
4 |
D |
$31.39 |
$1,726 |
D/D |
(55) |
23,639 |
|
- |
|
| Merrill Amelia |
SVP, People |
• – – |
2023-06-01 |
4 |
OE |
$0.00 |
$0 |
D/D |
158 |
23,694 |
|
- |
|
| Kalia Kumud |
Chief Information Officer |
• – – |
2023-06-01 |
4 |
D |
$31.39 |
$7,722 |
D/D |
(246) |
2,212 |
|
- |
|
| Kalia Kumud |
Chief Information Officer |
• – – |
2023-06-01 |
4 |
OE |
$0.00 |
$0 |
D/D |
710 |
2,458 |
|
- |
|
| Eagle Craig |
Chief Medical Officer |
• – – |
2023-05-15 |
4 |
D |
$27.89 |
$35,867 |
D/D |
(1,286) |
4,863 |
|
- |
|
| Eagle Craig |
Chief Medical Officer |
• – – |
2023-05-15 |
4 |
OE |
$0.00 |
$0 |
D/D |
3,718 |
6,149 |
|
- |
|
| Potter Myrtle S |
Director |
– • – |
2023-05-15 |
4 |
OE |
$0.00 |
$0 |
D/D |
68 |
1,299 |
|
- |
|
| Joyce Meghan V. |
Director |
– • – |
2023-05-04 |
4 |
OE |
$0.00 |
$0 |
D/D |
66 |
1,393 |
|
- |
|
| Dahne-Steuber Ines |
Chief Operating OfficerOfficer |
• – – |
2023-05-03 |
3 |
IO |
$0.00 |
$0 |
D/D |
0 |
1,000 |
|
- |
|
| Chudova Darya |
Chief Technology OfficerOffice |
• – – |
2023-05-03 |
3 |
IO |
$0.00 |
$0 |
D/D |
0 |
12,424 |
|
- |
|
| Potter Myrtle S |
Director |
– • – |
2023-04-15 |
4 |
OE |
$0.00 |
$0 |
D/D |
69 |
1,231 |
|
- |
|
| Saia John G. |
Chief Legal Officer |
• – – |
2023-04-15 |
4 |
D |
$24.50 |
$90,454 |
D/D |
(3,692) |
17,880 |
|
- |
|
| Saia John G. |
Chief Legal Officer |
• – – |
2023-04-15 |
4 |
OE |
$0.00 |
$0 |
D/D |
7,568 |
21,572 |
|
- |
|
| Joyce Meghan V. |
Director |
– • – |
2023-04-04 |
4 |
OE |
$0.00 |
$0 |
D/D |
67 |
1,327 |
|
- |
|
| Bell Michael Brian |
Chief Financial Officer |
• – – |
2023-03-15 |
4 |
D |
$26.78 |
$45,606 |
D/D |
(1,703) |
7,279 |
|
- |
|
| Bell Michael Brian |
Chief Financial Officer |
• – – |
2023-03-15 |
4 |
OE |
$0.00 |
$0 |
D/D |
4,931 |
8,982 |
|
- |
|
| Potter Myrtle S |
Director |
– • – |
2023-03-15 |
4 |
A |
$0.00 |
$0 |
D/D |
68 |
1,162 |
|
- |
|
| Eltoukhy Helmy |
Co-Chief Executive Officer |
• • – |
2023-03-15 |
4 |
B |
$26.15 |
$224,928 |
D/D |
8,600 |
2,049,238 |
2.81 |
- |
|
| Eltoukhy Helmy |
Co-Chief Executive Officer |
• • – |
2023-03-14 |
4 |
B |
$26.33 |
$2,223,908 |
D/D |
84,452 |
2,040,638 |
2.81 |
- |
|
| Joyce Meghan V. |
Director |
– • – |
2023-03-04 |
4 |
OE |
$0.00 |
$0 |
D/D |
66 |
1,260 |
|
- |
|
681 Records found
|
|
Page 7 of 28 |
|
|
| |
Transaction Code Key: |
Ownership Code Key |
| |
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
| |
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
| |
OE |
- Options Exercised |
A |
- Acquired |
| |
IO |
- Initital Ownership |
D |
- Disposed |
| |
|
|
|
|
|
